These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 27069507

  • 1. Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys?
    Korsgaard HO, Torgersen S, Wentzel-Larsen T, Ulberg R.
    Child Adolesc Psychiatry Ment Health; 2016; 10():8. PubMed ID: 27069507
    [Abstract] [Full Text] [Related]

  • 2. Personality disorders and Axis I comorbidity in adolescent outpatients with ADHD.
    Korsgaard HO, Torgersen S, Wentzel-Larsen T, Ulberg R.
    BMC Psychiatry; 2016 Jun 01; 16():175. PubMed ID: 27245754
    [Abstract] [Full Text] [Related]

  • 3. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives.
    Biederman J, Faraone SV.
    Psychiatr Clin North Am; 2004 Jun 01; 27(2):225-32. PubMed ID: 15063995
    [Abstract] [Full Text] [Related]

  • 4. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA, Harris SK, Kurland M, Knight JR.
    Pediatrics; 2003 Jun 01; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [Abstract] [Full Text] [Related]

  • 5. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
    van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S, IASP research group, van den Brink W, Schoevers RA.
    Addiction; 2014 Feb 01; 109(2):262-72. PubMed ID: 24118292
    [Abstract] [Full Text] [Related]

  • 6. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.
    Schieber LZ, Dunphy C, Schieber RA, Lopes-Cardozo B, Moonesinghe R, Guy GP.
    JAMA Psychiatry; 2023 Apr 01; 80(4):331-341. PubMed ID: 36790774
    [Abstract] [Full Text] [Related]

  • 7. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM, Malt UF, Opjordsmoen S.
    BMC Psychiatry; 2011 Feb 12; 11():25. PubMed ID: 21314980
    [Abstract] [Full Text] [Related]

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 12; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 9. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N, Dey M, Eich-Höchli D, Foster S, Gmel G, Mohler-Kuo M.
    Epidemiol Psychiatr Sci; 2016 Jun 12; 25(3):255-66. PubMed ID: 25989844
    [Abstract] [Full Text] [Related]

  • 10. [Attention-deficit hyperactivity disorder and personality disorders in treated in-patient and incarcerated adolescents].
    Sevecke K, Lehmkuhl G, Krischer MK.
    Prax Kinderpsychol Kinderpsychiatr; 2008 Jun 12; 57(8-9):641-61. PubMed ID: 19070205
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic comorbidity in hospitalized adolescents with conduct disorder.
    Fehon DC, Becker DF, Grilo CM, Walker ML, Levy KN, Edell WS, McGlashan TH.
    Compr Psychiatry; 1997 Jun 12; 38(3):141-5. PubMed ID: 9154369
    [Abstract] [Full Text] [Related]

  • 12. Attention-deficit hyperactivity disorder and nonsuicidal self-injury in a clinical sample of adolescents: the role of comorbidities and gender.
    Balázs J, Győri D, Horváth LO, Mészáros G, Szentiványi D.
    BMC Psychiatry; 2018 Feb 06; 18(1):34. PubMed ID: 29409473
    [Abstract] [Full Text] [Related]

  • 13. Substance use disorder and personality disorder.
    Sher KJ, Trull TJ.
    Curr Psychiatry Rep; 2002 Feb 06; 4(1):25-9. PubMed ID: 11814392
    [Abstract] [Full Text] [Related]

  • 14. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.
    Wilens TE, Biederman J, Martelon M, Zulauf C, Anderson JP, Carrellas NW, Yule A, Wozniak J, Fried R, Faraone SV.
    J Clin Psychiatry; 2016 Oct 06; 77(10):1420-1427. PubMed ID: 27574842
    [Abstract] [Full Text] [Related]

  • 15. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.
    Yule AM, Martelon M, Faraone SV, Carrellas N, Wilens TE, Biederman J.
    J Psychiatr Res; 2017 Feb 06; 85():49-55. PubMed ID: 27835739
    [Abstract] [Full Text] [Related]

  • 16. In-depth study of personality disorders in first-admission patients with substance use disorders.
    Langås AM, Malt UF, Opjordsmoen S.
    BMC Psychiatry; 2012 Oct 29; 12():180. PubMed ID: 23107025
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and comorbidity in a Swedish adolescent community sample - gambling, gaming, substance use, and other psychiatric disorders.
    Gerdner A, Håkansson A.
    BMC Psychiatry; 2022 Sep 06; 22(1):594. PubMed ID: 36068500
    [Abstract] [Full Text] [Related]

  • 18. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome.
    Ross S, Dermatis H, Levounis P, Galanter M.
    Am J Drug Alcohol Abuse; 2003 May 06; 29(2):263-79. PubMed ID: 12765206
    [Abstract] [Full Text] [Related]

  • 19. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H, Chouicha K, Montovany A, Callahan S, Duconge E, Sztulman H.
    Encephale; 2002 May 06; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [Abstract] [Full Text] [Related]

  • 20. Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity.
    Jahng S, Trull TJ, Wood PK, Tragesser SL, Tomko R, Grant JD, Bucholz KK, Sher KJ.
    J Abnorm Psychol; 2011 Aug 06; 120(3):656-69. PubMed ID: 21604829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.